Premorbid GLP1-RA use, SGLT2i use associated with lower 60-day mortality compared to premorbid DPP4i use
Read More »ADA: Peds Hospitalization Rates for New-Onset T2DM Up During Pandemic
Hospitalization rate for new onset diabetes up from 0.27 percent in 2019 to 0.62 percent in 2020; mean admission HbA1c, glucose also higher
Read More »ADA: Tirzepatide Noninferior, Superior to Semaglutide for T2DM
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
Read More »ADA: Efpeglenatide Lowers Risk for Adverse CV Events in T2DM
Findings among patients with type 2 diabetes and history of cardiovascular disease or current kidney disease
Read More »Walmart to Offer Low-Priced Insulin
Insulin prices have skyrocketed in recent years, making it unaffordable for some Americans with diabetes
Read More »Add-On PPI Therapy May Improve Glycemic Control in Diabetes
However, treatment with proton pump inhibitors is not associated with risk for incident diabetes in the general population
Read More »Bedside, Outside-the-Room Case Presentation Compared
Bedside case presentation more efficient for patient knowledge, but greater confusion about medical jargon, uncertainty due to team discussions
Read More »Claims Data Indicate Overuse of Levothyroxine in the U.S.
Among patients with available thyroid function test results, levothyroxine often initiated to treat subclinical hypothyroidism (61 percent)
Read More »Sotagliflozin Ups Days Alive, Out of Hospital in T2DM, Heart Failure
Increase in rate of days alive and out of hospital mainly due to drop in rate of days dead for patients with T2DM, worsening heart failure
Read More »BMI in Adolescence Linked to Poor Health Outcomes in Adulthood
Adolescent BMI z-score independently linked to poor general health, diabetes, premature myocardial infarction after 24-year follow-up
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.